Vinay Prasad, MD, MPH, a frequent critic of the FDA and COVID-19 lockdowns and vaccination policies, will be the next ...

A new trial suggests a combination vaccine may offer equal or better protection against both flu and covid-19 compared to ...

The Food and Drug Administration announced Tuesday it has picked a new head of its center charged with vaccine approvals and other biologics products: Dr. Vinay Prasad, a vocal critic of the agency's ...

Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

The advisory committee meeting is an important step in the process of readying boosters for the fall and winter season, but ...

On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...

FDA Commissioner ... During the COVID-19 pandemic, Prasad reached a much broader audience as a critic of mask mandates, lockdowns and moves to speed the availability of vaccine boosters from ...

Prasad is the latest in a series of medical contrarians and critics of COVID-19 measures ... held by an FDA career scientist. His appointment raises new questions about whether vaccines and ...

Scientists project that by 2026 the results of clinical trials being conducted in 25 countries, including Spain, will be ...